NIPPON SHINYAKU CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,335 JPY | +0.65% |
|
+3.09% | -13.23% |
| Apr. 10 | Jefferies Adjusts Nippon Shinyaku’s Price Target to 5,100 Yen From 6,900 Yen, Keeps at Buy | MT |
| Mar. 18 | Nippon Shinyaku Co., Ltd.(TSE:4516) dropped from S&P Japan Mid Cap 100 | CI |
ETFs positioned on Nippon Shinyaku Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.88% | 15 M€ | +7.34% | ||
| 0.23% | 60 M€ | +14.42% | ||
| 0.23% | 251 M€ | +13.17% | ||
| 0.16% | 11 M€ | +10.37% | - | |
| 0.13% | 4 M€ | +13.95% | ||
| 0.11% | 73 M€ | +11.61% | ||
| 0.08% | 18 M€ | +16.15% | - | |
| 0.07% | 10,207 M€ | +14.32% | ||
| 0.07% | 5,115 M€ | +13.58% | ||
| 0.05% | 66,066 M€ | +14.68% | - | |
| 0.05% | 144,586 M€ | +14.49% | ||
| 0.05% | 20,721 M€ | +13.52% | - | |
| 0.03% | 773 M€ | -.--% | - | |
| 0.03% | 7 M€ | +2.68% | - | |
| 0.01% | 10 M€ | -3.35% | - | |
| 0.01% | 31 M€ | +4.15% | - | |
| 0.00% | 206 M€ | -.--% | ||
| 0.00% | 23 M€ | -.--% | - | |
| 0.00% | 786 M€ | -.--% | ||
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 389 M€ | +6.76% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 607 M€ | +0.05% | - | |
| 0.00% | 1,166 M€ | +0.26% | - |
Nippon Shinyaku Co., Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceutical products and functional foodstuffs. The Company operates in two business segments. The Pharmaceutical segment is involved in the manufacture and sale of urinary system therapeutic agents, blood cancer therapeutic agents, pain, inflammation and allergic therapeutic agents, digestive system therapeutic agents, cardiovascular systems and metabolic therapeutic agents. The Functional Foodstuff segment involves in the manufacture and sale of health food materials, quality stability preservatives, protein preparation, spice and seasoning products. The Company is also involved in the business support business, non-life insurance agency business, as well as the provision of real estate leasing services.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
4,335
JPY
Average target price
6,371
JPY
Spread / Average Target
+46.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.23% | 1.85B | |
| +26.47% | 661B | |
| +26.74% | 566B | |
| -6.33% | 352B | |
| +19.35% | 332B | |
| +4.23% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.04% | 145B |
- Stock Market
- Equities
- 4516 Stock
- Funds and ETFs Nippon Shinyaku Co., Ltd.
